Lees Andrew, Barr Jackson F, Gebretnsae Samson
Fina Biosolutions LLC, 9430 Key West Ave, Suite 200, Rockville, MD 20850, USA.
School of Medicine, University of Maryland, Baltimore, MD 21201, USA.
Vaccines (Basel). 2020 Dec 18;8(4):777. doi: 10.3390/vaccines8040777.
CDAP (1-cyano-4-dimethylaminopyridine tetrafluoroborate) is employed in the synthesis of conjugate vaccines as a cyanylating reagent. In the published method, which used pH 9 activation at 20 °C (, 14:190, 1996), the rapid reaction made the process difficult to control. Here, we describe optimizing CDAP activation using dextran as a model polysaccharide. CDAP stability and reactivity were determined as a function of time, pH and temperature. While the rate of dextran activation was slower at lower pH and temperature, it was balanced by the increased stability of CDAP, which left more reagent available for reaction. Whereas maximal activation took less than 2.5 min at pH 9 and 20 °C, it took 10-15 min at 0 °C. At pH 7 and 0 °C, the optimal time increased to >3 h to achieve a high level of activation. Many buffers interfered with CDAP activation, but DMAP could be used to preadjust the pH of polysaccharide solutions so that the pH only needed to be maintained. We found that the stability of the activated dextran was relatively independent of pH over the range of pH 1-9, with the level of activation decreased by 40-60% over 2 h. The use of low temperature and a less basic pH, with an optimum reaction time, requires less CDAP, improving activation levels while making the process more reliable and easier to scale up.
1-氰基-4-二甲氨基吡啶四氟硼酸盐(CDAP)作为一种氰基化试剂用于合成结合疫苗。在已发表的方法中(该方法于20℃使用pH 9活化,, 14:190, 1996),快速反应使得该过程难以控制。在此,我们描述了以葡聚糖作为模型多糖来优化CDAP活化。测定了CDAP的稳定性和反应活性与时间、pH和温度的函数关系。虽然在较低pH和温度下葡聚糖的活化速率较慢,但CDAP稳定性的增加弥补了这一点,使得有更多的试剂可用于反应。在pH 9和20℃时,最大活化时间不到2.5分钟,而在0℃时则需要10 - 15分钟。在pH 7和0℃时,达到高活化水平的最佳时间增加到3小时以上。许多缓冲液会干扰CDAP活化,但4-二甲氨基吡啶(DMAP)可用于预先调节多糖溶液的pH,从而仅需维持pH即可。我们发现,在pH 1 - 9范围内,活化葡聚糖的稳定性相对独立于pH,在2小时内活化水平降低40 - 60%。使用低温和碱性较弱的pH,并配合最佳反应时间,所需的CDAP较少,提高了活化水平,同时使该过程更可靠且更易于扩大规模。